Regulatory Link:

The pharmaceutical industry is a research-intensive industry. It has a continuous commitment to the discovery, development and marketing of new medicines. Overtime, the development of a new drug is becoming more complex, time consuming and costly.

For any new drug, the regulatory approval requires submission of scientific documents from pharmaceutical firms to substantiate the clinical safety and efficacy of the drug. For details of the requirements for regulatory approvals in different parts of the world, visit the following sites.

International:
www.ich.org
www.who.org

Australia
www.health.gov.au/tga

Canada
www.hc-sc.gc.ca

Europe
www.heads.medagencies.org/
www.emea.eu.int

Hong Kong
www.info.gov.hk/pharmser

Japan
www.nihs.go.jp

New Zealand
www.medsafe.govt.nz

USA
www.MoH.gov